Health Condition 1: E785- Hyperlipidemia, unspecified
Conditions
Interventions
dosage and repetition (once or twice daily, as required and as appropriate) depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or fr
dosage and repetition (once or twice daily, as required and as appropriate) depending up
Sponsors
D N De Homoeopathic Medical College and Hospital
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients suffering from newly diagnosed cases of dyslipidaemia with LDL-C levels of 100-189 mg/dl 2.Age between 18 and 65 years 3.Framingham risk score 4.Literate patientsâ?? ability to read English, Hindi and/or Bengali. (Illiterate patients will be interviewed by the investigators maintaining adequate privacy to fill up the scales/questionnaires). 5.Providing with written informed consent voluntarily.
Exclusion criteria
Exclusion criteria: 1.Familial hypertriglyceridaemia. 2.Persons already taking lipid lowering agents. 3.History of myocardial infarction, stenting, coronary artery bypasses surgery or stroke. 4.Vulnerable population - unconscious, too sick for consultation, non-ambulatory, differently abled, terminally or critically ill patients, mentally incompetent people. 5.Uncontrolled hypertension, uncontrolled diabetes, nephritic syndrome, renal insufficiency, uncontrolled hypothyroidism, severe or active liver diseases or any other uncontrolled systemic diseases affecting quality of life or organ failure. 6.Diagnosed cases of unstable mental or psychiatric illness. 7.Tobacco chewing and/or smoking, alcoholism, and/or any other form(s) of substance abuse and/or dependence. 8.Pregnancy, puerperium, lactation. 9.Self-reported immuno-compromised state. 10.Undergoing homeopathic treatment for any chronic disease within the last 6 months. 11.Simultaneous participation in any other clinical trials.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Low-Density Lipoprotein Cholesterol (LDL-C)Timepoint: At baseline, after 2 months and after 4 months of intervention | — |
Secondary
| Measure | Time frame |
|---|---|
| Measure Yourself Medical Outcome Profile 2 (MYMOP-2) questionnaireTimepoint: Every month, up to 4 months of intervention.;Modified Naranjo Criteria for Homoeopathy (MONARCH) version-2Timepoint: After 4 months of intervention;Serum Triglycerides (TGs), Total cholesterol, Very-Low-Density Lipoprotein cholesterol (VLDL-C), High-density Lipoprotein cholesterol (HDL-C)Timepoint: At baseline, after 2 months and after 4 months of intervention | — |
Countries
India
Contacts
Public ContactDr Subhasish Ganguly
D N De Homoeopathic Medical College and Hospital
Outcome results
None listed